Reactivating nuclear PTEN to treat CLL. - Wikidata - awgldk - TriplyDB

Reactivating nuclear PTEN to treat CLL.

Reactivating nuclear PTEN to treat CLL.

http://www.wikidata.org/entity/Q42335075

about

Reactivating nuclear PTEN to treat CLL.

http://www.wikidata.org/entity/Q42335075

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Reactivating nuclear PTEN to treat CLL.

@en

Reactivating nuclear PTEN to treat CLL.

@nl

type

label

Reactivating nuclear PTEN to treat CLL.

@en

Reactivating nuclear PTEN to treat CLL.

@nl

prefLabel

Reactivating nuclear PTEN to treat CLL.

@en

Reactivating nuclear PTEN to treat CLL.

@nl

P1433

Q42335075-EEE6E58E-E590-44BA-B3C9-5F7C62A388FB

P1476

Q42335075-BBE7CFF5-9FBD-4271-A820-69E9070C83C2

P2093

Q42335075-FED146CB-3070-42C8-92C7-88E19E94C572

P2860

Q42335075-18D50EAB-C9A5-4820-AEC6-9DF22892ABC5

Q42335075-5A0CC0C8-CA4E-413D-AF8C-ED99E9C02068

Q42335075-A0521768-197F-45F5-BB5B-BEC329003594

Q42335075-A4607B61-472F-4E59-B636-655037E1CC8E

Q42335075-A8D7F268-5AAC-4572-BA00-BB68BCE5A3DB

Q42335075-B96C4E2C-CFA8-4103-AFA1-01FDD94C214F

Q42335075-D8B26B93-835B-4842-9CB6-1E4A5A2FFBCE

Q42335075-E2CFC0AA-4511-4C8F-AC56-D2E00F88D01C

P304

Q42335075-7CA5804F-D8F5-4241-AC44-9F217B920A9A

P31

Q42335075-3E6DBA0A-0DA3-4FBE-9236-B44939E510D4

P356

Q42335075-14BAD5E6-AB8A-4CE0-96FB-D84D490F092A

P407

Q42335075-63BA00BA-FB3E-41B0-AEED-DDB64281EC61

P433

Q42335075-B768D6BA-765C-44DC-A3D4-C813DE9290C5

P478

Q42335075-A5E67C0A-FE3B-4C0A-A7CE-D787C7531EB3

P50

Q42335075-ADE417A6-AFEA-40DD-94B4-CC2BEB2EF0C4

P577

Q42335075-EC41B48C-7ACC-4425-8379-7E0147ED6468

P698

Q42335075-EE3B8415-E0F9-462E-85CD-399AD515181D

P932

Q42335075-7CCFC0D1-9EA5-4C27-896C-F69EDA35A355

P356

ONCOTARGET.17543

P1433

P1476

Reactivating nuclear PTEN to treat CLL

@en

P2093

Paolo Ghia

http://www.w3.org/2001/XMLSchema#string

P2860

The functions and regulation of the PTEN tumour suppressor

Management of chronic lymphocytic leukemia.

miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation.

A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.

HAUSP is required for p53 destabilization.

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.

Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia.

Low expression level of phosphatase and tensin homolog deleted on chromosome ten predicts poor prognosis in chronic lymphocytic leukemia.

P304

35486-35487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17543

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28473667

http://www.w3.org/2001/XMLSchema#string

P932

5482590

http://www.w3.org/2001/XMLSchema#string